Re: Presentation is over
in response to
by
posted on
Jun 09, 2020 01:26PM
It looks good, agreed, but the problem with the CVD data in low GFR patients is small numbers of patients and lack of stratified randomisation (randomisation after slection on the basis of low GFR). This might be the basis for another trial to confirm the benefit.